News Summary

• PTSD can develop after traumatic experiences such as military combat, serious accidents, natural disasters, or violence.
• An estimated 6% of Americans will experience PTSD during their lifetime.
• Treatment has largely centered on psychotherapy and medications known as selective serotonin reuptake inhibitors (SSRIs), including sertraline and fluoxetine.
• The newly cleared system uses Magnetic e-Resonance Therapy (MeRT), a technology that combines measurements of brain activity with targeted magnetic stimulation.
• It should open up market access to about 13 million people who may be struggling with PTSD.